One‐year safety and efficacy results of insulin treatment simplification with <scp>IDegLira</scp> in type 2 diabetes-Reference-Cited by-同舟云学术

One‐year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes

Published:2022-12-03 Issue:1 Volume:6 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrino Diabet & Metabol

Author:

Taybani Zoltán J.¹,Bótyik Balázs¹,Gyimesi András¹,Katkó Mónika²,Várkonyi Tamás³

Affiliation:

1. Department of Endocrinology Dr. Réthy Pál Member Hospital, Békés County Central Hospital Békéscsaba Hungary

2. Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine University of Debrecen Debrecen Hungary

3. Department of Internal Medicine University of Szeged Szeged Hungary

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.390

Reference21 articles.

1. 9. Pharmacologic approaches to glycemic treatment: standards of medical Care in Diabetes—2022;Committee ADAPP;Diabetes Care,2021

2. Clinical practice guideline – diagnosis, antihyperglycaemic treatment and care of patients with diabetes in adulthood;Jermendy G;Diabetologia Hungarica,2017

3. Early Insulinization to Prevent Diabetes Progression

4. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update

5. Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification;Diabetes Therapy;2024-06-27

2. The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol;Diabetes Therapy;2024-04-24

3. Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study;Diabetes Therapy;2024-04-11

4. IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study;Diabetes, Obesity and Metabolism;2024-02-08